This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
11/4/2026
Ladies and gentlemen, thank you for standing by. Today's conference call will begin momentarily. Until that time, your lines will be again placed on hold music. Thank you for your patience. Thank you for watching! Good day and thank you for standing by. Welcome to Green Thumb Industries' third quarter 2026 earnings call. Please be advised that today's conference is being recorded. I would like to now hand the conference over to your first speaker today, Ashley Dunn, Vice President, Communications. Please go ahead.
Thank you, operator. Good afternoon and welcome to Green Thumb's third quarter 2026 earnings call. I'm here today with founder and CEO, Ben Kovler. President Anthony Georgiadis and Chief Financial Officer Matt Faulkner. Today's discussions and responses to questions may include forward-looking statements which are subject to various risks and uncertainties that could cause our actual results to differ materially from these statements. These risks and uncertainties are detailed in the earnings press release issued today. along with the reports filed with the United States Securities and Exchange Commission and Canadian securities regulators including our most recent annual report filed on Form 10-K. This report along with today's earnings release can be found under the Investors section of our website. Green Thumb assumes no obligation to update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this call. Throughout the discussion, Green Fund will refer to non-GAAP financial measures, including EBITDA, normalized EBITDA, and adjusted EBITDA. A reconciliation of non-GAAP financial measures to the most directly comparable GAAP measures is included in our earnings press release and SEC and CDAR Plus filings. Please note that all financial information is provided in U.S. dollars unless otherwise indicated. Thanks, everyone. And now, here's Ben.
Thank you, Ashley. Good afternoon, everyone, and thank you for joining Green Thumb's third quarter 2026 earnings call. Let me start with the bigger picture before we get to the quarter. For more than a decade, Green Thumb has operated in an industry defined by uncertainty. No federal framework, no roadmap, and no guarantee that the rules in place today will be the rules tomorrow. Navigating that uncertainty isn't a side skill for us. It's a core competency. Our formula has not changed. We build brands people love, invest in our team, and protect the balance sheet. We delivered on all three again this quarter. On the last call, we talked about the industry being on the cusp of meaningful federal change. And the honest update is today that process is ongoing. Medical cannabis is on Schedule 3, which is real progress. But the broader rescheduling decision is still pending. The federal landscape remains the single biggest wildcard in our industry. But here's what we've learned. For years, we saw uplisting to a major U.S. exchange as the catalyst that would unlock value in this sector. But we've seen that a listing alone doesn't change how investors value the business. What institutions need is federal certainty, clarity on scheduling, and clarity on taxes. That's the real unlock, and that's where we're focusing our energy with policymakers and the investment community. Tax clarity is a big part of that. Section 280E no longer applies to our medical business, and Treasury and the IRS have made guidance on 280E one of their priorities for fiscal 2027. How soon that clarity arrives matters for us and for every operator trying to model its tax position. Separately, Our DEA registration process is progressing, with certain medical licenses now registered in Florida and Virginia and others pending. At the state level, Massachusetts voters overwhelmingly chose to keep the state's adult use program in place, with over 75% voting no on Question 8. So while the industry is still in flux, we remain engaged across all kinds of regulatory scenarios. You can see that continued discipline in this quarter's results. Third quarter revenue came in at $324 million, up 11% year over year. Normalized EBITDA was $89 million, or approximately 28% of revenue. That margin is in line with the third quarter of last year, even with the pricing pressure we continue to see in several markets. Cash flow from operations was $58 million, a solid step up from the second quarter. We ended the quarter with $316 million in cash on the balance sheet, and this gives us real flexibility on how we deploy that capital. Pricing pressure persists in several of our markets, but our results remain a credit to our brands and to our team. Hemp policy is another area we're watching very closely. Under current federal law, intoxicating hemp products become illegal on December 11th, and a number of states have already moved ahead with their own bans or restrictions. Our position is that unregulated, untaxed, and untested products don't belong on store shelves. We've long viewed THC beverages as a distinct category from intoxicating hemp products, and we believe they should exist in a regulated market. These products have demonstrated real consumer appeal from major retailers to stadiums and entertainment venues. THC beverages are emerging as a viable fourth adult beverage category, right alongside beer, wine, and spirits. Leading retailers and wholesalers have played an important role in that progress, and their backing has given the category credibility. Even with the forthcoming changes to federal law, consumers continue to reach for these beverages. We should establish a reasonable framework for its future. Through all of this, our brands remain strong. At the end of the third quarter, Rhythm ranked number one nationally in branded flour. and Dog Walkers ranked number one nationally in uninfused pre-rolls. Dog Walkers is also marking its 10-year anniversary this year, reflecting a decade of building brand equity with consumers. Cannabis is not a niche anymore. It's competing for the same consumer as some of the biggest names in consumer packaged goods and beverage alcohol. And these companies are paying attention. Many are starting to invest in alternatives to alcohol, in some cases alongside live entertainment partners, which signals where the consumer is going. Green Thumb has the right brand, the cash flow, and the balance sheet to weather the regulatory uncertainty in the near and medium term. And that means we can be patient as we build these brands for the long run. On the capital allocation front, we continue to weigh three uses. Growth capex as new state markets open up, M&A, and buybacks. In September, our board authorized a new $50 million share repurchase program. Since Q4 2023, we've returned more than $200 million to shareholders. Purchasing about 29.5 million shares, or roughly 13% of the company, at an average price of about $7 per share. Going forward, we'll continue watching for opportunities, and when the time is right, choose whichever creates the most long-term value for our shareholders. One balance sheet note before I wrap up. On October 10, 2026, we began consolidating Rhythm Inc. into Green Thumb's financial statements, rather than the equity method accounting. This was triggered by the removal of the cap on converting our rhythm notes and warrants, which requires consolidation under accounting rules. To be clear, we didn't buy any shares or convert any of our derivative securities. Our current ownership has not changed, and we currently have no plans to convert. To close, regardless of federal policy, our business has real value that the market is not fully recognizing yet. Federal Clarity should help unlock that, first by changing how investors view the industry, then through growth. But until then, we'll keep growing the business, investing in our team, returning capital to shareholders when it makes sense, and moving decisively when opportunities come. Before I hand it over to Anthony, I want to thank our team, many of whom are listening right now, and we would not be where we are today without all of you, so thank you. With that, I'll hand it over to Anthony.
You're reading a preview of the GTBIF Q3 2026 earnings call.
Free account.
Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.
Use this data in your own app
Pull this call's transcript, audio and slides with the Earnings call transcripts API.
See pricing